Callan Family Office’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$460K Sell
2,081
-1,239
-37% -$303K 0.01% 793
2025
Q4
$842K Buy
3,320
+1,655
+99% +$416K 0.02% 600
2025
Q3
$412K Sell
1,665
-171
-9% -$40.9K 0.01% 599
2025
Q2
$441K Buy
+1,836
New +$427K 0.01% 629

Other funds holding STE

Callan Family Office's STE Position: Q1 2026 in Review

Callan Family Office reduced its Steris (STE) stake by 37% in Q1 2026, selling an estimated $303K and leaving 2,081 shares worth $460K. The position accounts for 0.01% of the portfolio, ranked #793.

Callan Family Office first reported a position in STE in Q2 2025 and has held it in 4 quarters since. The position peaked at $842K in Q4 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Callan Family Office held 2,081 shares of Steris worth $460K as of Q1 2026.
  • Callan Family Office sold 1,239 Steris shares in Q1 2026, an estimated $303K.
  • Steris made up 0.01% of Callan Family Office's portfolio in Q1 2026, its #793 holding.
  • Callan Family Office first reported a position in Steris in Q2 2025 and has held it in 4 quarters since.
  • Callan Family Office's Steris position peaked at $842K in Q4 2025.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.